Melatonin and Fasenra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melatonin (melatonin) and Fasenra (benralizumab). Common drug interactions include pneumonia among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Melatonin and Fasenra. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.

What is Fasenra?

Fasenra has active ingredients of benralizumab. eHealthMe is studying from 11,805 Fasenra users. Check the latest studies of Fasenra.

On Jul, 13, 2026

43 people who take Melatonin and Fasenra together, and have interactions are studied.

Melatonin and Fasenra drug interactions.

What are the common drug interactions of Melatonin and Fasenra, by gender? *:

female:

Pneumonia
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Erythema (redness of the skin)
Herpes zoster
Inflammation
Lung disorder (lung disease)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Onychoclasis (breaking of the nails)
Pain
Scleroderma (hard skin)

male:

Asthma
Drug effect decreased
Arthralgia (joint pain)
Dry skin
Dyspnoea exertional (breathlessness or shortness of breath)
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)
Respiratory tract infection
Rhonchi (abnormal breath sounds)
Skin discolouration (change of skin colour)

What are the common drug interactions of Melatonin and Fasenra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Erythema (redness of the skin)
Feeling hot
Injection site urticaria (rash of round, red welts on the skin at injection site)
Joint dislocation (a joint position is changed from normal position)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Post procedural discharge
Post procedural swelling
Pyrexia (fever)
Scratch

50-59:

Cystic fibrosis (disease of the secretary glands)
Weight fluctuation
Fatigue (feeling of tiredness)
Pneumonia
Nausea (feeling of having an urge to vomit)
Asthma
Drug effect decreased
Asthenia (weakness)
Constipation
Cough

60+:

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Weight decreased
Lacrimation increased
Lung disorder (lung disease)
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Multiple allergies (allergy to multiple agents)
Onychoclasis (breaking of the nails)
Pain
Pruritus (severe itching of the skin)
Scleroderma (hard skin)

What are the existing conditions these people have? *

Asthma: 16 people, 37.21%
Primary Immunodeficiency Syndrome: 13 people, 30.23%
Immunodeficiency Common Variable: 13 people, 30.23%
Immune System Disorder: 5 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Melatonin and Fasenra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously